首页 | 本学科首页   官方微博 | 高级检索  
     


Phase II study of pirarubicin in advanced non-small cell lung cancer
Affiliation:1. Département de Médecine, Institut Gustave-Roussy, Villejuif, France;2. Laboratoire Roger Bellon, Neuilly, France;1. Department of Molecular Biology and Biotechnology, Faculty of Biology and Geology, Babes-Bolyai University, Cluj-Napoca, Romania;2. Molecular Biology Centre, Institute for Interdisciplinary Research in Bio-Nano-Sciences, Babes-Bolyai University, Cluj-Napoca, Romania;3. Department of Pharmaceutical Technology and Biopharmaceutics, Faculty of Pharmacy, University of Medicine and Pharmacy “Iuliu Hatieganu”, Cluj-Napoca, Romania;1. School of Mathematical Sciences, Universiti Sains Malaysia, 11800, USM, Penang, Malaysia;2. Department of Food Science and Technology, Faculty of Applied Sciences, Universiti Teknologi MARA, 40450, Shah Alam, Selangor, Malaysia;3. Food Technology Division, School of Industrial Technology, Universiti Sains Malaysia, 11800, USM, Penang, Malaysia;2. Bioceramed S.A., 2660-360 São Julião do Tojal, Loures, Portugal;1. Department of Food Science and Engineering, School of Chemistry and Chemical Engineering, Harbin Institute of Technology, No.73 Huanghe Road, Nangang District, Harbin, Heilongjiang Province 150090, PR China;2. Key Laboratory of Agro-product Quality and Safety, Institute of Quality Standard & Testing Technology for Agro-Product, Chinese Academy of Agricultural Sciences, Beijing 100081, PR China;3. Department of Pharmacology and Toxicology, Beijing Institute of Radiation Medicine, No. 27 Taiping Road, Haidian District, Beijing 100850, PR China
Abstract:
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号